Acne Treating Drug, Zanatane, Launched in US Market by Dr Reddy's Laboratories

by Raja Nandhini on  March 30, 2013 at 2:28 AM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Drug firm Dr Reddy's Laboratories has received the approval from USFDA for its drug Zanatane capsules and has launched the drug in the US market.
 Acne Treating Drug, Zanatane, Launched in US Market by Dr Reddy's Laboratories
Acne Treating Drug, Zanatane, Launched in US Market by Dr Reddy's Laboratories

The capsules available in the strengths of 10 mg, 20 mg and 40 mg and in boxes of 30 are used to treat severe form of acne namely, severe recalcitrant nodular acne.

The capsules are generic version of Accutane (Isotretinoin Capsules USP) of Hoffman- La Roche Inc.

This launch has hiked the value of the company's shares.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Acne Stress Relief Through Alternative Medicine Skin Disease Rashes Symptom Evaluation Exfoliate Hidradenitis Suppurativa Top 10 Ways to Clear Acne Blackheads / Comedones Ten Most Common Skin Disorders Foods That Can Make Skin Oily 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...